From July 1, 2023 to September 30, 2023, the company has repurchased 1,072,041 shares, representing 2.2% for $50 million. With this, the company has completed the repurchase of 10,078,173 shares, representing 21.3% for $228.89 million under the buyback announced on November 8, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.07 USD | -0.94% | +1.65% | -30.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.36% | 2.13B | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- AMPH Stock
- News Amphastar Pharmaceuticals, Inc.
- Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016.